Latest News about XBI
Recent news which mentions XBI
From Motley Fool
From Benzinga
2 Must-Own Biotech Stocks to Buy in May
April 29, 2021
From InvestorPlace
These 5 biotech ‘busted IPOs’ look attractive now that the sectorwide selloff seems over
April 27, 2021
From MarketWatch
These 5 biotech ‘busted IPOs’ look attractive now that the sectorwide selloff seems over
April 27, 2021
From MarketWatch
Greater Regulatory Scrutiny Could Weigh on Biotech ETFs
March 24, 2021
From ETF Trends
From Motley Fool
Why Moderna Stock Is Slipping Today
March 17, 2021
From Motley Fool
Biotech stocks are a buy — especially these 18 picks
March 09, 2021
From MarketWatch
Why CRSP Stock Is a Less Dicey Risk Asset Today
March 09, 2021
From InvestorPlace
From Motley Fool
From Benzinga
From MarketWatch
Short Sellers Still Targeting Retail, Biotech ETFs
February 18, 2021
From Benzinga
3 Biotech Stocks to Buy As Things Heat Up for the Sector
February 18, 2021
From InvestorPlace
Here’s one strategist’s road map for investors who want to dodge ‘stonks’ and ride inflation
February 17, 2021
From MarketWatch
How To Improve Your Investment Future In Just 10 Minutes
February 10, 2021
From Benzinga
Short-Sellers Have These 3 ETFs in Their Sights
February 03, 2021
From Motley Fool
Charting a bullish February start: S&P 500 spikes from major support
February 02, 2021
From MarketWatch
Is Gilead Sciences Stock a Buy?
January 27, 2021
From Motley Fool
Why I'm Betting Big on This 1 Megatrend
January 25, 2021
From Motley Fool
Fear of new virus variant pushes U.S. toward more genomic sequencing
January 15, 2021
From MarketWatch
3 Top Biotech Picks for 2021
January 10, 2021
From Motley Fool
From MarketWatch
How to make money in 2021 — follow these three stock market takeaways from last year
January 06, 2021
From MarketWatch
Consider Smaller Biotech ETFs as Big Pharma Goes Shopping in 2021
December 31, 2020
From ETF Trends
Health experts slam delayed vaccine rollout in U.S. as early effort falls far short of expectations
December 29, 2020
From MarketWatch
Arcturus Therapeutics shares slide 37% in premarket after COVID vaccine data are deemed ‘underwhelming’
December 29, 2020
From MarketWatch
Myovant shares soar 27% on news of Pfizer prostate cancer drug collaboration worth up to $4.2 billion
December 28, 2020
From MarketWatch
ETF Wrap: Marcia, Marcia, Marcia!
December 17, 2020
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.